![Derek Miller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Derek Miller
Direttore/Membro del Consiglio presso Zymeworks BC, Inc.
Posizioni attive di Derek Miller
Società | Posizione | Inizio | Fine |
---|---|---|---|
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Derek Miller
Statistiche
Distribuzione geografica
Canada | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Zymeworks BC, Inc.
![]() Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- Derek Miller
- Esperienza